B+
Bull case
25%
Probability
Target price
$0.85
Analysis reference price unavailable
Analysis 2026-07-16 · RankAlpha Sentiment Codex
NXGL
NexGelANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The mid-April acquisition creates a potential step-up in revenue exposure, adds commercial-stage products with stated reimbursement pathways, and brings a strategic financing and distribution partner. Q2 is the first meaningful test of whether that opportunity is visible in reported results [#PR-EARNINGS-2026-05-16].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
510(k) pipeline timing and commercialization remain uncertain and may require additional capital [#PR-EARNINGS-2026-05-16].
Momentum
89
Value
36
Sentiment
86
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.52 · Bull $0.85 · Bear $0.22Analysis 2026-07-16; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-08-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-08-18
Investment thesis
As of 2026-08-18
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-08-18. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $2.00
Why
Momentum89 · Δ7d -
Value36 · Δ7d -0.0
Sentiment86 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • 510(k) pipeline timing and commercialization remain uncertain and may require additional capital [#PR-EARNINGS-2026-05-16].
- • Acquisition integration and sales execution are unproven in reported results because Q1 excluded acquisition revenue [#PR-EARNINGS-2026-05-16].
- • Q1 revenue declined to $2.65 million from $2.81 million year over year, while cash was limited and acquisition integration had not yet been reflected in revenue.
Catalyst clock
2026-10-14
BioNX acquisition begins contributing to reported revenue
Lead driver: Sentiment · See AI snapshot
Momentum
89
10% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
40% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.0
Sentiment
86
49% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 88.8 / Value 36.4 / Sentiment 85.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-16. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$0.52
Analysis reference price unavailable
Analysis 2026-07-16 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$0.22
Analysis reference price unavailable
Analysis 2026-07-16 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$4.44M
Beta
0.59
Shares Out
9.23M
P/E (TTM) · Derived
-1.3
P/S (TTM)
1.24
P/FCF (TTM) · Derived
-2.55
Rev YoY
-5.6%
EPS YoY
+21.4%
Gross Margin
+38.1%
Op Margin
-25.5%
Net Debt
$2.03M
Current Ratio
1.70
As of 2026-08-18 • Updated nightlySource: Internal modelMethods & Data